NL0015285958 - IMTXW (XNAS)
IMMATICS NV- WARRANTS Aktie
2,85 USD
Aktuelle Kurse von IMMATICS NV- WARRANTS
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
NASDAQ |
IMTXW
|
USD
|
18.09.2024 20:43
|
2,85 USD
| 3,00 USD | -5,00 % |
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,00 % | -10,80 % | 11,76 % | -20,83 % | -18,10 % | -20,17 % | -48,18 % |
Firmenprofil zu IMMATICS NV- WARRANTS Aktie
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products pipeline includes IMA203 that targets solid tumors, which is in Phase 1b clinical trial; IMA203CD8, a cell therapy product that is in Phase 1b clinical trial; IMA204 that targets tumor stroma, which is in preclinical stage; and IMA30x, an allogenic cellular therapy product candidate, which is in preclinical stage. The company also develops TCR Bispecifics products, including IMA401, which is in Phase 1b clinical trial; and IMA402 and IMA403, which are in preclinical stages. The company has a strategic collaboration agreement with MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies; Celgene Corporation to develop novel adoptive cell therapies targeting multiple cancers; and Genmab A/S to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics N.V. is headquartered in Tübingen, Germany.
Unternehmensdaten zur IMMATICS NV- WARRANTS Aktie
Name IMMATICS NV- WARRANTS
Firma immatics biotechnologies GmbH
Symbol IMTXW
Website https://www.immatics.com
Heimatbörse
NASDAQ
ISIN NL0015285958
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Dr. Harpreet Singh Ph.D.
Marktkapitalisierung 1 Mrd.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,4 T
Adresse Paul-Ehrlich-Strasse 15, 72076 Tübingen
IPO Datum 2020-07-02
Ticker Symbole
Name | Symbol |
---|---|
NASDAQ | IMTXW |
Weitere Aktien
Investoren die IMMATICS NV- WARRANTS halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024